NeuroGenetic Pharmaceuticals (United States)

NeuroGenetic Pharmaceuticals (United States)

Open Access statistics for NeuroGenetic Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023.

Open Access statistics for NeuroGenetic Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

78%


Total
Publications

54


Total Open
Publications

42


Total
Citations

2.3K


Open Access
Percentage

78%


Total
Publications

54


Total Open
Publications

42


Total
Citations

2.3K

Website

download

Breakdown

19% 52% 7% 22%

Publisher Open

19%

Both

52%

Other Platform Open

7%

Closed

22%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

50%OA Journal

OA Journal 50%

19

Hybrid 29%

11

No Guarantees 21%

8

Other Platform Open

Domain 97%

31

Institution 31%

10

Other Internet 16%

5

Preprint 3%

1

Public 3%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
31
Europe PMC
Domain
13
Washington University School of Medicine - Digital Commons@Becker
Institution
7
wustl.edu OAI-PMH Repository
Institution
3
University of Edinburgh - Edinburgh Research Explorer
Institution
3
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
2
University of Bristol - Bristol Research
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - Aix-Marseille Université
Institution
2
King's College London - Research Portal
Institution
2
California Digital Library - eScholarship
Other Internet
2
1 / 3

Data updated 13 May 2024

Share

Share

Share